Crossmark

Refining the path to clinical translation: a critical appraisal of exosome therapeutics refining the path to clinical translation: a critical appraisal of exosome therapeutics

Crossref DOI link: https://doi.org/10.1186/s12967-026-07823-w

Published Online: 2026-02-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, DuJiang

Ye, Zhijun

Yang, Jiexiang

Wang, GuoYou https://orcid.org/0000-0003-0027-0572
Funding

Funding for this research was provided by:

The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical UniversitThe Affiliated Traditional Chinese Medicine Hospital of Southwest Medical Universit (2023ZYQJ02)
License Information

Text and Data Mining valid from 2026-02-13

Version of Record valid from 2026-02-13
More Information

Article History

Received: 3 October 2025

Accepted: 14 November 2025

First Online: 13 February 2026

Declarations

:

: Ethical approval was not required.

: Not applicable.

: Not applicable.

: All authors have no conflicts of interest or financial ties to disclose.

Document is current

Any future updates will be listed below